Clinical Trials Browser

Phase 2/3 × Recruiting × Breast × Clear all

NCT04715958 2026-02-17

Prediction of Neoadjuvant Chemotherapy Response Using Contrast-Enhanced Ultrasound in Patients With Locally Advanced Breast Cancer

Phase 2/3 Recruiting

Anatomic Stage III Breast Cancer AJCC v8

NCT07373782 2026-01-28

Continuous Positive Airway Pressure (CPAP) Assisted Radiotherapy in Breast Cancer

Phase 2/3 Recruiting

Microcephaly, Primary Autosomal Recessive, 6, Breast Neoplasms

NCT05860465 2026-01-14

Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast Cancer

Phase 2/3 Recruiting

Breast Neoplasms

NCT07310758 2025-12-30

Contrast-enhanced Ultrasound for Sentinel Node Detection

Phase 2/3 Recruiting

BreastDermatologicHead & Neck

Breast Neoplasms, Head and Neck Neoplasms, Melanoma

NCT06891833 2025-10-02

A Study of BL-M07D1 With or Without Pertuzumab Versus Taxane + Trastuzumab and Pertuzumab in Neoadjuvant Therapy for HER2-Positive Breast Cancer

Phase 2/3 Recruiting

HER2-positive Breast Cancer

NCT05744687 2025-08-17

Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer

Phase 2/3 Recruiting

Breast Neoplasms

NCT06958627 2025-05-06

any

Phase 2/3 Recruiting

HER2 Positive Breast Cancer

NCT05288777 2025-04-18

Breast53

Phase 2/3 Recruiting

Breast Neoplasms

NCT05804916 2023-04-07

Optical Surface Monitoring Technology-Guided Large-Segment Radiotherapy for Breast Cancer

Phase 2/3 Recruiting

Breast Neoplasms

NCT04803539 2023-02-21

Artemis

Phase 2/3 Recruiting

Breast Neoplasms

NCT04576143 2021-08-12

Efficacy and Safety of Dose-dense Chemotherapy (ddEC-ddP) for Neoadjuvant Chemotherapy of HER2-negative Breast Cancer

Phase 2/3 Recruiting

HER2-negative Breast Cancer